title: Re: Christoph A. Von Klot, Markus A. Kuczyk, Axel S. Merseburger. No androgen withdrawal syndrome for enzalutamide: a report of disease dynamics in the postchemotherapy setting. Eur Urol 2014;65:258-9: Enzalutamide withdrawal syndrome: fact or fiction?
authors.affiliation: Department of Urology, Ulm University Medical Center, Ulm, Germany.
authors.forename: Andres J
authors.initials: AJ
authors.lastname: Schrader
authors.affiliation: Department of Urology, Ulm University Medical Center, Ulm, Germany.
authors.forename: Mark G
authors.initials: MG
authors.lastname: Schrader
authors.affiliation: Department of Urology, Ulm University Medical Center, Ulm, Germany. Electronic address: marcus.cronauer@uni-ulm.de.
authors.forename: Marcus V
authors.initials: MV
authors.lastname: Cronauer
mesh_terms: D059002:Androgen Receptor Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010669:Phenylthiohydantoin / Q000031:analogs & derivatives*; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome / Q000209:etiology*
chemical_list: D059002:Androgen Receptor Antagonists; D010669:Phenylthiohydantoin